Question

A 59-year-old with nonsevere CDI asks about adjunctive therapy to reduce recurrence risk after standard-of-care antibiotics. Which is reasonable in high-risk patients?

Accepted Answer

Bezlotoxumab infusion during standard therapy

Answer

Probiotics

Answer

Fecal microbiota transplant as first-line

Answer

Long-term vancomycin suppressive therapy

Answer

Stop therapy early

Practice question

A 59-year-old with nonsevere CDI asks about adjunctive therapy to reduce recurrence risk after standard-of-care antibiotics. Which is reasonable in high-risk patients?